Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

aTYR PHARMA (ATYR) Amortizatization of Intangibles (2019 - 2025)

Historic Amortizatization of Intangibles for aTYR PHARMA (ATYR) over the last 7 years, with Q3 2025 value amounting to $512000.0.

  • aTYR PHARMA's Amortizatization of Intangibles fell 1592.78% to $512000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 3297.24%. This contributed to the annual value of $2.7 million for FY2024, which is 1469.57% down from last year.
  • aTYR PHARMA's Amortizatization of Intangibles amounted to $512000.0 in Q3 2025, which was down 1592.78% from $458000.0 recorded in Q2 2025.
  • In the past 5 years, aTYR PHARMA's Amortizatization of Intangibles registered a high of $977000.0 during Q3 2023, and its lowest value of -$237000.0 during Q1 2022.
  • Its 5-year average for Amortizatization of Intangibles is $508473.7, with a median of $550000.0 in 2024.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first tumbled by 23465.91% in 2022, then skyrocketed by 38481.01% in 2023.
  • Over the past 5 years, aTYR PHARMA's Amortizatization of Intangibles (Quarter) stood at $212000.0 in 2021, then skyrocketed by 210.38% to $658000.0 in 2022, then surged by 35.71% to $893000.0 in 2023, then plummeted by 38.41% to $550000.0 in 2024, then decreased by 6.91% to $512000.0 in 2025.
  • Its last three reported values are $512000.0 in Q3 2025, $458000.0 for Q2 2025, and $523000.0 during Q1 2025.